National Healthcare Agreement: PI 02-Incidence of selected cancers, 2015
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Indicator type:||Progress measure|
|Short name:||PI 02-Incidence of selected cancers, 2015|
|Description:||Incidence of selected cancers of public health importance.|
Health, Standard 07/07/2010
|Quality statement:||National Healthcare Agreement: PI 02-Incidence of selected cancers, 2015 QS Health, Superseded 08/07/2016|
Collection and usage attributes
Rates directly age-standardised to the 2001 Australian population.
Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-economic Disadvantage (IRSD) are based on the state or territory and Statistical Local Area (SLA) of the person at the time of their diagnosis.
Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published.
100,000 × (Numerator ÷ Denominator)Calculated separately for each type of cancer.
For melanoma, bowel and lung cancer: Number of new cases in the reported year.
For cervical and breast cancer in females: Number of new cases in females in the reported year.
|Numerator data elements:|
For melanoma, bowel and lung cancer: Total population.For cervical and breast cancer in females: Total female population.
|Denominator data elements:|
2011—Nationally (for each cancer type), by 2011 Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-economic Disadvantage (IRSD) deciles.
2011—State and territory (for each cancer type), by:
2007, 2008, 2009, 2010 (resupplied for updated Indigenous ERP), 2011—State and territory (for each cancer type), by:
Some disaggregation may result in numbers too small for publication.
Disaggregation by SEIFA and remoteness data are subject to availability of suitable population data.
|Disaggregation data elements:|
Most recent data available for 2015 National Healthcare Agreement (NHA) performance reporting: 2011.
2011 data for NSW and ACT will not be available for inclusion and will be estimated for the state and territory by cancer type disaggregation. 2011 estimated data for NSW and ACT will not be disaggregated by Indigenous status, remoteness or SEIFA IRSD quintiles.
2010 incidence data will be resupplied to include incidence rates for New South Wales and the Australian Capital Territory, which were supplied as estimates in the 2014 report.
|Unit of measure:||Disease type|
Indicator conceptual framework
|Framework and dimensions:||Health conditions|
Data source attributes
|Reporting requirements:||National Healthcare Agreement|
|Organisation responsible for providing data:||Australian Institute of Health and Welfare|
|Further data development / collection required:||Specification: Final, the measure meets the intention of the indicator.|
|Related metadata references:|
Supersedes National Healthcare Agreement: PI 02-Incidence of selected cancers, 2014
Has been superseded by National Healthcare Agreement: PI 02–Incidence of selected cancers, 2016
See also National Healthcare Agreement: PI 24-Survival of people diagnosed with notifiable cancers, 2015